Approval · Notice of Compliance 37528 · 2026
PHESGO: Notice of Compliance 37528
Issued May 13, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37528
- Date
- May 13, 2026
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Changes to the drug substance manufacturing facility
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PHESGO | Not yet assigned | — |
Medicinal ingredients
- TRASTUZUMAB 40 MG per ML
- PERTUZUMAB 80 MG per ML
- TRASTUZUMAB 60 MG per ML
- PERTUZUMAB 60 MG per ML